Introduction
Peroxisome proliferators-activated receptors γ (PPARγ) is a ligands-activated nuclear transcription factor. Activated PPAR γ binds to the peroxisome proliferator responsive element in the promoter of target gene to regulate gene expression [1, 2] . For the past few years, PPAR γ has been considered as a well-known antiaging molecule [3, 4] . Activated PPAR γ plays a role in regulating adipocyte differentiation and lipid metabolism, improving insulin resistance, inhibiting inflammatory reaction [5] and upregulating longevity gene expression such as Klotho [6] . Previous studies reported that PPAR γ inactivation by phosphorylation was observed in many kinds of tissues, such as kidney [7] , cerebral cortex [8] and fat [9] , suggesting that PPAR γ phosphorylation may play an important role in the initiation and development of aging and leads to functional disorder and aberrant expression
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Keywords: P-PPAR γ Spontaneously hypertensive rat Thoracic aorta Rosiglitazone Aging of downstream target gene. Vascular aging can change the threshold and severity of cardiovascular diseases including hypertension [10] . It is an independent risk factor for the increasing incidence of hypertension with older age [10, 11] [13] . Rats were respectively divided into WKY (n=9), SHR (n=9) and SHR+rosiglitazone groups (n=9). Rats in the SHR+rosiglitazone group were treated with rosiglitazone (5 mg/ kg) daily for 8 weeks through intragastric administration. While, rats in the WKY and SHR groups were treated with the same volume of saline. Blood pressure measurement was performed after treatment. After treatment, systolic blood pressure (SBP) was measured using tail cuff method as previous described [14] . All rats were sacrificed by cervical vertebra dislocation under anesthesia with ether and the thoracic aorta tissues were excised and prepared for routine pathological examination with HematoxylinEosin (HE) staining [13] . Some thoracic aorta tissues (n=3) were subjected to immunohistochemical analysis, and some (n=6) were homogenized and the proteins extracted for immunoblotting. All animal protocols were approved by the Institutional Animal Care and Use Committee of Xi'an Jiaotong University.
Materials and methods

In vivo experiments
Immunohistochemical staining
Immunohistochemistry was performed on paraformaldehyde- 
Western blot
The total proteins were isolated from thoracic aorta and measured MA, USA) (1:5 000) and p-PPARγ (1:800) primary antibodies were used in the immunoblotting assays. Horseradish peroxidaseconjugated goat anti-mouse or anti-rabbit secondary antibodies (Bio-Rad, Hercules, CA, USA) were used at a 1:1 000-1: 5 000 dilution and detected using a Western Blotting Luminol Reagent (sc-2048; Santa Cruz Biotechnology), as described in previous study [15] .
Statistical analysis
The data were analyzed using the SPSS statistical package for 
Results
The SBP of SHR and WKY rats with different age
As shown in Figure 1, Figure 2 ), while 16
week-old rats showed the lowest SBP (P<0.05, respectively, Figure 2 ).
The structure of thoracic aorta in SHR and WKY rats with different age
As shown in Figure 3 , HE staining showed the layer of elastic fibers was no big change, but exhibited increased content of smooth muscle cell, wrinkled lining endothelium and increased thickness of internal elastic lamina in the thoracic aorta of SHR.
These histopathological changes were worsened by the increase of age. The histopathological changes in SHR+rosiglitazone group were less than those in SHR group. WKY group only showed increased layer of elastic fibers with the increase of age. But other histopathological changes were not observed in WKY group.
The expression of p-PPARγ in the thoracic aorta of rats
The thoracic aortas arising from rats in different groups were subjected to immunostaining for p-PPARγ. As shown in Figure   4 , our results found that p-PPARγ signal was increased by the increase of age in both SHR and WKY rats. P-PPAR γ signal in SHR group was obviously higher than that in matched WKY group.
However, SHR+rosiglitazone group showed less p-PPARγ signal 
Discussion
Vascular aging is mainly characterized as characteristic remodeling of the structure and function by the increase of age, which is an independent risk factor for promoting the incidence of hypertension [10, 11] . In this study, SBP were measured using a tail cuff method. Our data indicated that the SBP in SHR was elevated by the increase of age. HE staining showed that the histopathological changes including increased content of smooth muscle cell, wrinkled lining endothelium and increased thickness of internal elastic lamina in the thoracic aorta of SHR were worsened by the increase of age. These results indicate that vascular aging is observed in the thoracic aorta of SHR. PPAR γ acts as a nuclear transcription factor for regulating several senescenceassociated genes [3] [4] [5] [6] . PPAR γ phosphorylation is an important post-transcriptional modification and it has been found in many aging diseases [7] [8] [9] . However, whether PPAR γ phosphorylation is presented in vascular aging induced hypertension has not been investigated. We, for the first time, approved that p-PPARγ was observed in the thoracic aorta of 16, 32 and 64 week-old SHR by the increase of age, which was consistent with vascular aging in the thoracic aorta. These results suggest that PPAR γ phosphorylation is enhanced during hypertension related vascular aging. But the priority of PPAR γ phosphorylation or vascular aging needs to be further confirmed.
Different phosphorylated residues of PPAR γ in different cells and under different stimulations exert different biological effects [16] .
Mitogen-activated protein kinases induce the phosphorylation of PPAR γ on Ser112 and inhibit PPAR γ activity [17] [18] [19] . However, cyclindependent kinase 7 (Cdk7) and Cdk9 lead to phosphorylation of PPAR γ on Ser112 and increase PPAR γ activity [20, 21] . Otherwise, Cdk5 mediates Ser273 phosphoryaltion, which is located at hinge region between PPAR γ DNA binding domain and ligand binding domain, to regulate target gene expression [12] . Our studies just detected the level of p-PPARγ with Ser273 phosphorylation. Thus, the level of p-PPARγ with Ser112 phosphorylation still needs further studies. Previous studies have approved that PPAR γ agonist, rosiglitazone, inhibits Cdk5 mediated phosphorylation of PPAR γ on Ser273 in adipocytes and is independent of canonical receptor transcriptional activation signaling pathway [12] . Our studies further confirmed that rosiglitazone inhibits the phosphorylation of PPAR γ on Ser273 in the thoracic aorta of SHR. But further researches are needed to confirm that the effect is mediated by Cdk5 pathway or not. Otherwise, PPAR γ functions as a nuclear transcription factor for regulating many target gene expression. Whether rosiglitazone binds to PPAR γ and regulates phosphorylation related target gene expression to inhibit PPAR γ phosphorylation still need to be approved.
In conclusion, PPAR γ phosphorylation is observed in the thoracic aorta of SHR during vascular aging. Furthermore, the level of p-PPARγ protein is up-regulated by the increase of age.
Rosiglitazone inhibits PPAR γ phosphorylation and vascular aging.
These results contribute to revealing the mechanisms involved in hypertension vascular aging.
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